Cora Sternberg is the last author on this practice changing study. This study is important because it highlights the need to provide an accurate radiological monitoring, added to PSA tests, during the follow-up of patients with metastatic hormone-sensitive prostate cancer or nonmetastatic castration-resistant prostate cancer receiving enzalutamide treatment.
Excellence in the Cancer Therapeutics Research Program: Cora Sternberg honored in Research.com's 2025 global ranking.
Artificial intelligence (AI) has the potential to transform cancer therapeutic decision-making by improving diagnostics and personalizing treatments.
Provide scholarships to Italian oncologists, biologists and other health care members for projects related to Precision Medicine
Help young bright oncologists to establish connections with the EIPM and other International Cancer centers
Provide treatments for Oncology patients that have been identified though Precision Medicine
To create a bridge between Italian patients and this cutting-edge new way to treat cancer
Bring Precision Medicine to Italian Hospitals and Italian patients in collaboration with International Consortia
Create connections between different specialists in Italy such as oncology, pathology, radiology and bioinformatics
Create awareness and education among health professionals and patients about the benefits of Precision Medicine
Making new drugs available to patients will be one important goal of the Foundation